Local monitoring center for clozapine therapy: Quality assurance of drug treatment in a group of psychiatric patients;Lokalt monitoreringssenter for klozapin (Leponex)-behandling

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 7, 1998, Pages 1076-1078

  Bakken, Kjersti ^a,f   Bratlid, Trond ^b   Erlandsen, Christian ^c   Lingjærde, Odd ^d   Nome, Siri ^e  

^a Åsgård Sykehus   (Norway)

^b Åsgård Sykehus   (Norway)

^c Sanderud Sykehus   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

^e Sandviken Sykehus   (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

DRUG BLOOD LEVEL; DRUG MONITORING; EARLY DIAGNOSIS; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; LEUKOPENIA; MENTAL DISEASE; NORWAY; PATIENT COMPLIANCE; PRESCRIPTION; SHORT SURVEY;

EID: 0032502298     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (4)

1. Kane J, Honigfeld G, Singer J, Meltzer HY. Clozapine for the treatment of resistant schizofrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789-96.
2. Tørisen HM, red. Felleskatalogen 1996/97; 38. utgave. Oslo: Felleskatalogen A/S, 1996.
3. Gadeholt G. Forenklet utlevering av Leponex «Sandoz Pharma» (klozapin). Nytt om legemidler 1996, 19: 158.
4. Honigfeld G. Effects of the Clozapine National Registry System on incidence of deaths related to agranulocytosis. Psychiatr Serv 1996; 47: 52-6.